Literature DB >> 26809455

[Therapy of mitral regurgitation is set in motion].

K-H Kuck1, H Thiele2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 26809455     DOI: 10.1007/s00059-015-4400-6

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


× No keyword cloud information.
  7 in total

Review 1.  The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?

Authors:  Francesco Maisano; Ottavio Alfieri; Shmuel Banai; Maurice Buchbinder; Antonio Colombo; Volkmar Falk; Ted Feldman; Olaf Franzen; Howard Herrmann; Saibal Kar; Karl-Heinz Kuck; Georg Lutter; Michael Mack; Georg Nickenig; Nicolo Piazza; Mark Reisman; Carlos E Ruiz; Joachim Schofer; Lars Søndergaard; Gregg W Stone; Maurizio Taramasso; Martyn Thomas; Alec Vahanian; John Webb; Stephan Windecker; Martin B Leon
Journal:  Eur Heart J       Date:  2015-04-12       Impact factor: 29.983

2.  Guidelines on the management of valvular heart disease (version 2012).

Authors:  Alec Vahanian; Ottavio Alfieri; Felicita Andreotti; Manuel J Antunes; Gonzalo Barón-Esquivias; Helmut Baumgartner; Michael Andrew Borger; Thierry P Carrel; Michele De Bonis; Arturo Evangelista; Volkmar Falk; Bernard Iung; Patrizio Lancellotti; Luc Pierard; Susanna Price; Hans-Joachim Schäfers; Gerhard Schuler; Janina Stepinska; Karl Swedberg; Johanna Takkenberg; Ulrich Otto Von Oppell; Stephan Windecker; Jose Luis Zamorano; Marian Zembala
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

Review 3.  Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation.

Authors:  Ole De Backer; Nicolo Piazza; Shmuel Banai; Georg Lutter; Francesco Maisano; Howard C Herrmann; Olaf W Franzen; Lars Søndergaard
Journal:  Circ Cardiovasc Interv       Date:  2014-06       Impact factor: 6.546

4.  Percutaneous repair or surgery for mitral regurgitation.

Authors:  Ted Feldman; Elyse Foster; Donald D Glower; Donald G Glower; Saibal Kar; Michael J Rinaldi; Peter S Fail; Richard W Smalling; Robert Siegel; Geoffrey A Rose; Eric Engeron; Catalin Loghin; Alfredo Trento; Eric R Skipper; Tommy Fudge; George V Letsou; Joseph M Massaro; Laura Mauri
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

5.  Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.

Authors:  Michael A Acker; Michael K Parides; Louis P Perrault; Alan J Moskowitz; Annetine C Gelijns; Pierre Voisine; Peter K Smith; Judy W Hung; Eugene H Blackstone; John D Puskas; Michael Argenziano; James S Gammie; Michael Mack; Deborah D Ascheim; Emilia Bagiella; Ellen G Moquete; T Bruce Ferguson; Keith A Horvath; Nancy L Geller; Marissa A Miller; Y Joseph Woo; David A D'Alessandro; Gorav Ailawadi; Francois Dagenais; Timothy J Gardner; Patrick T O'Gara; Robert E Michler; Irving L Kron
Journal:  N Engl J Med       Date:  2013-11-18       Impact factor: 91.245

6.  Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation.

Authors:  Daniel Goldstein; Alan J Moskowitz; Annetine C Gelijns; Gorav Ailawadi; Michael K Parides; Louis P Perrault; Judy W Hung; Pierre Voisine; Francois Dagenais; A Marc Gillinov; Vinod Thourani; Michael Argenziano; James S Gammie; Michael Mack; Philippe Demers; Pavan Atluri; Eric A Rose; Karen O'Sullivan; Deborah L Williams; Emilia Bagiella; Robert E Michler; Richard D Weisel; Marissa A Miller; Nancy L Geller; Wendy C Taddei-Peters; Peter K Smith; Ellen Moquete; Jessica R Overbey; Irving L Kron; Patrick T O'Gara; Michael A Acker
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

7.  Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial.

Authors:  Tomasz Siminiak; Justina C Wu; Michael Haude; Uta C Hoppe; Jerzy Sadowski; Janusz Lipiecki; Jean Fajadet; Amil M Shah; Ted Feldman; David M Kaye; Steven L Goldberg; Wayne C Levy; Scott D Solomon; David G Reuter
Journal:  Eur J Heart Fail       Date:  2012-05-21       Impact factor: 15.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.